Overview
TYRA market data
Price History
TYRA price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.01 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.74 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $9.96 – $40.65 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $2K · P/B 5.41.
Company News
TD Synnex To Rally More Than 8%? Here Are 10 Top Analyst Forecasts For FridayBenzinga · Jun 12, 2026, 12:55 PM
Intel To Rally Around 26%? Here Are 10 Top Analyst Forecasts For ThursdayBenzinga · Jun 11, 2026, 11:49 AM
This Hanover Insurance Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For TuesdayBenzinga · May 19, 2026, 2:35 PM
This Stubhub Analyst Turns Bullish; Here Are Top 4 Upgrades For TuesdayBenzinga · May 19, 2026, 2:35 PM
This Interface Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For TuesdayBenzinga · May 19, 2026, 1:30 PM
Wolfe Research Initiates Coverage On Tyra Biosciences with Peer Perform RatingBenzinga · May 19, 2026, 12:15 PM
HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $45 Price TargetBenzinga · May 14, 2026, 10:31 AM
Tyra Biosciences Q1 EPS $(0.64) Misses $(0.59) EstimateBenzinga · May 13, 2026, 12:09 PM
8-K filing — Tyra Biosciences, Inc. (TYRA)SEC EDGAR · May 13, 2026, 12:00 PM